Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy

Pan Song,Zirui Gao,Yige Bao,Li Chen,Yuhe Huang,Yanyan Liu,Qiang Dong,Xiawei Wei

DOI: https://doi.org/10.1186/s13045-024-01563-4

IF: 28.5

2024-06-20

Journal of Hematology & Oncology

Abstract:The Wnt/β-catenin signaling pathway plays a crucial role in various physiological processes, encompassing development, tissue homeostasis, and cell proliferation. Under normal physiological conditions, the Wnt/β-catenin signaling pathway is meticulously regulated. However, aberrant activation of this pathway and downstream target genes can occur due to mutations in key components of the Wnt/β-catenin pathway, epigenetic modifications, and crosstalk with other signaling pathways. Consequently, these dysregulations contribute significantly to tumor initiation and progression. Therapies targeting the Wnt/β-catenin signaling transduction have exhibited promising prospects and potential for tumor treatment. An increasing number of medications targeting this pathway are continuously being developed and validated. This comprehensive review aims to summarize the latest advances in our understanding of the role played by the Wnt/β-catenin signaling pathway in carcinogenesis and targeted therapy, providing valuable insights into acknowledging current opportunities and challenges associated with targeting this signaling pathway in cancer research and treatment.

oncology,hematology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about the role of the Wnt/β - catenin signaling pathway in cancer development and its potential as a target for cancer treatment. Specifically, the paper aims to:

1. **Review the important roles of the Wnt/β - catenin signaling pathway in physiological processes**: The Wnt/β - catenin signaling pathway plays a crucial role in multiple physiological processes such as cell proliferation, differentiation, apoptosis, migration, invasion and tissue homeostasis.

2. **Explore the abnormal activation of the Wnt/β - catenin signaling pathway in cancer development**: The abnormal activation of the Wnt/β - catenin signaling pathway is closely related to the occurrence and development of various cancers, including solid tumors, hematological malignancies and sarcomas. The paper discusses in detail the mechanisms of this abnormal activation, including gene mutations, epigenetic modifications and interactions with other signaling pathways.

3. **Evaluate the treatment strategies targeting the Wnt/β - catenin signaling pathway**: Although some inhibitors (such as bufalin, curcumin, vitamin D, sulindac and glutaminase 1) have been found to be able to block the carcinogenesis process, most of the studies are still in the pre - clinical stage. The paper summarizes the research progress of these inhibitors and explores the prospects and challenges of developing effective drugs in the future.

4. **Provide a comprehensive perspective and insights**: The paper aims to provide researchers and clinicians with the latest understanding of the Wnt/β - catenin signaling pathway in cancer development and treatment, as well as the current opportunities and challenges, by synthesizing the existing research results.

In conclusion, the goal of this review paper is to comprehensively summarize the role of the Wnt/β - catenin signaling pathway in cancer development and provide a scientific basis for the development of new treatment strategies.